COMMUNIQUÉS West-GlobeNewswire
-
Zealand Pharma major shareholder announcement: Bank of America Corporation
16/08/2024 - 18:05 -
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/08/2024 - 22:05 -
Theriva Biologics Announces Reverse Stock Split
16/08/2024 - 22:05 -
Codexis Announces New Employment Inducement Grants
16/08/2024 - 22:05 -
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
16/08/2024 - 22:14 -
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
16/08/2024 - 22:15 -
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million
16/08/2024 - 22:30 -
Alignment Healthcare Updates its Board of Directors
16/08/2024 - 22:30 -
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
16/08/2024 - 22:30 -
Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform
15/08/2024 - 14:00 -
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024 - 14:00 -
Lifeward Reports Second Quarter 2024 Financial Results
15/08/2024 - 14:00 -
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer
15/08/2024 - 14:00 -
Noah Medical Shares Diagnostic Confidence of its Galaxy Users at AABIP 2024
15/08/2024 - 14:00 -
Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit
15/08/2024 - 14:00 -
Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
15/08/2024 - 14:00 -
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
15/08/2024 - 14:00 -
Pathos Expands Pipeline With Worldwide License of Phase 2-ready Brain-penetrant, PRMT5 Inhibitor
15/08/2024 - 14:00 -
LIXTE Biotechnology Holdings to Present at Two Investor Conferences
15/08/2024 - 14:30
Pages